In-House Monofilament & Braiding
Global Export Destinations
Validated EO Sterilization Level
Guaranteed Shelf-Life Stability
Precision-engineered polyglycolic acid (PGA) and polyglactin 910 surgical sutures with swaged stainless steel needles optimized for Korean surgical standards.
Polyglycolic Acid (PGA) represents the pinnacle of synthetic bio-absorbable surgical polymers. Synthesized through the ring-opening polymerization of glycolide, PGA provides predictable hydrolytic degradation without relying on enzymatic digestion—an essential characteristic for modern surgical procedures where consistent bio-absorption profiles are non-negotiable.
When deployed in vascularized soft tissue, high-purity PGA sutures demonstrate superior tensile strength profiles compared to natural organic materials. The structural integrity is retained through critical wound healing phases:
| Implantation Time | Tensile Strength Retention (%) | In-Vivo Degradation Stage | Clinical Relevance |
|---|---|---|---|
| Day 7 | 85% – 90% | Initial Polymer Chain Hydrolysis | Critical fascia & soft tissue opposition phase |
| Day 14 | 65% – 75% | Controlled Amorphous Region Breakdown | Standard wound closure support period |
| Day 21 | 40% – 50% | Crystalline Phase Dissolution | Secondary tissue remodeling stage |
| Day 28 | 15% – 25% | Mass Fragmentation Begins | Reduced stress shielding effect |
| Day 60 – 90 | 0% (Complete Absorption) | Full Resorption into Glycolate | Zero foreign body presence remaining |
Our PGA sutures utilize premium AISI 300 and 400 series stainless steel needles featuring micro-point geometry. Laser-drilled needle ends ensure an ultra-smooth attachment junction (swage) that matches the outer diameter of the suture thread, reducing penetration trauma by up to 35% compared to conventional channeled needles. Each braided filament is coated with a precise ratio of Polycaprolactone and Calcium Stearate, imparting a silky surface finish that effortlessly glides through delicate tissue while maintaining exceptional knot security and knot tie-down precision.
South Korea’s advanced medical system requires strict adherence to international quality standards across specialized medical sectors. Our PGA surgical suture configurations are engineered to meet the stringent demands of top-tier hospital networks in Seoul, Busan, Incheon, and Daegu.
In Seoul's high-density aesthetic medical hubs (Gangnam & Apgujeong), 5-0 and 6-0 fine-gauge PGA sutures are extensively specified for subcuticular closures, blepharoplasty, and rhinoplasty. Minimal tissue drag prevents track marks, ensuring optimal cosmetic scar healing.
Korean dental clinics favor rapid-absorbable PGA (PGA Rapide) for mucosal adaptation following dental implants and wisdom tooth extractions. Complete resorption within 42 days eliminates the necessity of uncomfortable secondary suture removal visits for patients.
Leading general surgery departments utilize heavy-gauge PGA (USP 0, 1, 2) with 1/2 circle round-bodied needles for deep muscle and peritoneal closure, achieving rapid knot security during laparoscopic and open abdominal interventions.
Importers and medical distributors entering or scaling within the South Korean market must navigate a distinct regulatory landscape overseen by the Ministry of Food and Drug Safety (MFDS), formerly known as KFDA.
Surgical sutures in South Korea are categorized under Class II and Class III medical devices depending on structural composition and absorption rate. Our manufacturing facility in Bengaluru, India provides complete Summary Technical Documentation (STED) aligned with MFDS standards, including ISO 10993 biocompatibility testing, sterilization validation, and raw material traceability certificates.
Korean healthcare institutions are rapidly phasing out animal-derived gut sutures in favor of synthetic absorbable polymers due to BSE concerns and inconsistent absorption. Synthetic PGA and PGLA 910 are now recognized as the gold standard across public hospital purchasing boards.
Local Korean regulations mandate that primary foil packages and outer boxes display clear, standardized Hangul product details, lot numbers, expiration dates, and UDI (Unique Device Identification) barcode structures. We offer full OEM customized packaging services tailored for Korean distributors.
As an ISO 13485:2016 and WHO-GMP certified medical device exporter, we operate a fully integrated, single-site manufacturing plant in Bengaluru, India, serving healthcare importers across 50+ countries.
From polymer extrusion, filament braiding, micro-coating, and needle swaging to final ethylene oxide (EO) sterilization—zero steps are outsourced, guaranteeing flawless lot-to-lot consistency.
We supply CE / EU MDR 2017/745 certificates, Declarations of Conformity, Free Sale Certificates (FSC), Certificate of Analysis (CoA), and 11-year post-market surveillance data tracking.
We maintain reliable freight corridors directly from Nhava Sheva and Chennai sea ports to Incheon Port and Busan Port, with air-freight options to Incheon International Airport (ICN) for quick delivery times.
Direct B2B factory pricing, full regulatory dossier support, and sample kits prepared for South Korean importers, tender agents, and brand owners.
